RecruitingNCT06538064
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Studying Chronic inflammatory demyelinating polyneuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Takeda
- Principal Investigator
- Study DirectorTakeda
- Intervention
- No Intervention(other)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (15)
- Samir Macwan MD Inc, Rancho Mirage, California, United States
- Neuro/Psych Sleep Clinic, San Francisco, California, United States
- Yale School Of Medicine, New Haven, Connecticut, United States
- Nova Clinical Research, LLC, Bradenton, Florida, United States
- Suncoast Neuroscience Associates, Inc., St. Petersburg, Florida, United States
- Hawaii Pacific Neuroscience, Honolulu, Hawaii, United States
- HSHS St. Elizabeths Hospital, O'Fallon, Illinois, United States
- University of Kansas Medical Center Research Institute, Inc., Kansas City, Kansas, United States
- Wake Forest University - School of Medicine - Central, Winston-Salem, North Carolina, United States
- Arhus Universtitetshospital, Aarhus N, Denmark
- Rigshospitalet, København Ø, Denmark
- Immanuel Klinik Rudersdorf, Rüdersdorf, Brandenburg, Germany
- Universitaetsklinikum Giessen und Marburg GmbH Standort Marburg, Marburg, Hesse, Germany
- Katholisches Klinikum Bochum gGmbH, Bochum, North Rhine-Westphalia, Germany
- Judisches Krankenhaus Berlin, Berlin, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06538064 on ClinicalTrials.govOther trials for Chronic inflammatory demyelinating polyneuropathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07540221A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyGrifols Therapeutics LLC
- RECRUITINGPHASE3NCT06752356A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Kedrion S.p.A.
- RECRUITINGNCT07273903Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart DevicesHeinrich-Heine University, Duesseldorf
- RECRUITINGPHASE3NCT07091630A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPargenx
- ENROLLING BY INVITATIONPHASE2NCT07188844An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Immunovant Sciences GmbH
- RECRUITINGNCT07154524Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)University of Ulm
- RECRUITINGPHASE3NCT06920004A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPargenx
- RECRUITINGNCT07264426Real-World Efgartigimod Effectiveness in CIDP: A Prospective Studyargenx
See all trials for Chronic inflammatory demyelinating polyneuropathy →